No Data
No Data
InflaRx | 6-K: Report of foreign private issuer (related to financial reporting)
Sector Update: Health Care Stocks Advance Monday Afternoon
Health care stocks rose in Monday afternoon trading, with the NYSE Health Care Index adding 0.7% and the Health Care Select Sector SPDR Fund (XLV) up 0.6%. The iShares Biotechnology ETF (IBB) climbed
Sector Update: Health Care
Health care stocks rose Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both adding 0.7%. The iShares Biotechnology ETF (IBB) rose 1.9%. In corporate
InflaRx Anti-Inflammatory Drug Chosen for Phase 2 Acute Respiratory Distress Syndrome Trial; Shares Rise
InflaRx (IFRX) said Monday that the Biomedical Advanced Research and Development Authority has selected its anti-inflammatory drug Gohibic, or vilobelimab, for a Phase 2 clinical trial evaluating opti
Express News | InflaRx Shares Are Trading Higher After the Company Announced GOHIBIC Was Selected by BARDA for a Phase 2 Study on Acute Respiratory Distress Syndrome
Express News | InflaRx Announces GOHIBIC (Vilobelimab) Selected By BARDA For Phase 2 Study On Acute Respiratory Distress Syndrome; One Of Three Investigational Therapies Chosen By U.S. Department Of Health And Human Services
No Data